Form 4: DENTSPLY SIRONA SVP Vests 8,861 Shares

Andrea L. Frohning, SVP and CHRO of DENTSPLY SIRONA Inc., acquired 8,861 shares of common stock through the vesting of performance-based restricted stock units.

Summary

• Andrea L. Frohning, SVP, CHRO of DENTSPLY SIRONA Inc. (XRAY), acquired 8,861 shares of common stock.
• The acquisition occurred on March 2, 2026, at a price of $0 per share, indicating a vesting event.
• These shares resulted from the vesting of performance-based restricted stock units (PRSUs) that were originally granted on March 3, 2023.
• The Compensation Committee certified the attainment of performance criteria, with 1,478 PRSUs specifically noted as attained on March 2, 2026, leading to the acquisition of 8,861 shares.
• Following this transaction, Ms. Frohning beneficially owns 42,863.252 shares of DENTSPLY SIRONA Inc. common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive indicator, reflecting successful attainment of performance goals and increased insider alignment, though it's a routine compensation event.

Positives

• The vesting of performance-based restricted stock units indicates that DENTSPLY SIRONA Inc. met certain performance criteria set by its Compensation Committee.
• Increased insider ownership aligns management interests with shareholder interests, potentially signaling confidence in the company's future.

Future Outlook

The filing indicates the successful completion of a past performance period, leading to the vesting of executive compensation. It does not provide forward-looking guidance on future company performance or strategic initiatives beyond the scheduled vesting of these specific units.

Industry Context

StockSavvy.ai notes that insider transactions, particularly vesting events like this, are common in executive compensation structures across various industries. They typically reflect the fulfillment of long-term incentive plans tied to company performance, aligning executive interests with shareholder value creation. This specific filing for DENTSPLY SIRONA Inc. is a routine disclosure of such an event.

Comparison to Industry Standards

• Executive compensation through performance-based restricted stock units (PRSUs) is a standard practice in publicly traded companies, including those in the medical device and dental supply industry, such as Align Technology (ALGN) or Zimmer Biomet (ZBH).
• The vesting of PRSUs upon meeting performance criteria is a common mechanism to incentivize long-term performance, similar to how executives at companies like Johnson & Johnson (JNJ) or Medtronic (MDT) receive equity awards.
• The increase in beneficial ownership for a Senior Vice President and Chief Human Resources Officer (CHRO) is consistent with typical executive equity holdings in companies of DENTSPLY SIRONA's size and market capitalization.

Stakeholder Impact

• Shareholders: The vesting indicates that the company met certain performance targets, which is generally positive for shareholders. Increased insider ownership can also be seen as a positive alignment of interests.
• Management: Andrea L. Frohning's compensation package has been successfully realized, increasing her equity stake in the company.

Next Steps

• The shares acquired from the vesting of PRSUs will be held by Andrea L. Frohning as part of her beneficial ownership in DENTSPLY SIRONA Inc.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event (vesting of PRSUs) and does not contain new information regarding the company's operational performance, financial outlook, or strategic direction that would warrant a change in investment recommendation. It primarily confirms the successful achievement of past performance targets and an increase in insider ownership, which is generally a neutral to slightly positive signal, supporting a 'hold' stance for existing investors.

Keywords

DENTSPLY SIRONA, XRAY, Insider Transaction, Form 4, Stock Vesting, Restricted Stock Units, Executive Compensation, Andrea Frohning